ornithine has been researched along with Left Ventricular Dysfunction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunborg, C; Brunvand, L; Dahl-Jørgensen, K; Fugelseth, D; Hanssen, KF; Heier, M; Margeirsdottir, HD; Stensaeth, KH | 1 |
| Ahmadi, A; Beisswenger, PJ; Blackburn, NJR; Brownlee, M; Cimenci, CE; Gonzalez-Gomez, M; McNeill, B; Milne, RW; Ostojic, A; Suuronen, EJ; Vulesevic, B; Zhong, Z | 1 |
| Bonz, A; Burkard, N; Cartwright, EJ; Frantz, S; Hallhuber, M; Hofmann, U; Hu, K; Kaufmann, SG; Maier, LS; Maier, SK; Neyses, L; Renné, T; Ritter, O; Rokita, AG; Schuh, K; Wu, R | 1 |
3 other study(ies) available for ornithine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function.
Topics: Adolescent; Age Factors; Biomarkers; Biomechanical Phenomena; Blood Pressure; Body Mass Index; Carotid Artery, Common; Carotid Intima-Media Thickness; Child; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Diastole; Echocardiography, Doppler; Elastic Modulus; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Imidazoles; Immunoassay; Logistic Models; Male; Odds Ratio; Ornithine; Predictive Value of Tests; Risk Factors; Up-Regulation; Vascular Stiffness; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right; Ventricular Function, Left; Ventricular Function, Right | 2017 |
Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction.
Topics: Animals; Apoptosis; Cells, Cultured; Collagen Type I; Disease Models, Animal; Genetic Predisposition to Disease; Glycation End Products, Advanced; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Lactoylglutathione Lyase; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Ornithine; Phenotype; Pyruvaldehyde; Signal Transduction; Stem Cells; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility.
Topics: Animals; Arginine; Caffeine; Calcium; Calcium Channels, L-Type; Calcium Signaling; Cell Size; Cells, Cultured; Citrulline; Cyclic GMP; Doxycycline; Enzyme Induction; Ion Channel Gating; Mice; Mice, Transgenic; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide Synthase Type I; Ornithine; Protein Interaction Mapping; Recombinant Fusion Proteins; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2007 |